The U.S. Food and Drug Administration (FDA) has officially recognized that data submitted from the Aurora and Beacon clinical trials conducted by Disc Medicine sufficiently demonstrate that its investigational drug Bitopertin can significantly reduce protoporphyrin (Ppix) levels in patients' blood.

The CEO of HPE stated during a conference call that the current upward trend in component and memory prices is expected to continue until 2027.

Bright Horizons Family Solutions Inc. has approved a new stock repurchase program, authorizing the repurchase of up to $600 million of the company's common stock.

The CEO of Hewlett Packard Enterprise pointed out that the entire industry is currently experiencing significant commodity supply shortages and rising cost pressures.

Envirotech Vehicles Inc. has confirmed that the company officially signed a securities purchase agreement with institutional investor Ya Ii Pn, Ltd. on March 6, 2026.